-
Healthcare Resource Utilization Associated With Myotonic Dystrophy Type 1 With Complex Care Needs: Results From the Real-World IMPaCT Study
Mar 10, 2025, 14:00 PM -
Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access
Mar 10, 2025, 14:00 PM -
Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19
Mar 10, 2025, 14:00 PM -
Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China
Mar 10, 2025, 14:00 PM -
Transfusion Needs For Patients With Myelofibrosis In Latin America
Mar 10, 2025, 14:00 PM -
Gabapentinoid Use, Potential Misuse, and Associated Risk Factors among U.S. Adult Cancer Survivors: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Sotagliflozin for Patients With Type 1 Diabetes and Chronic Kidney Disease, With and Without Dynamic Pricing
Mar 10, 2025, 14:00 PM -
Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States
Mar 10, 2025, 14:00 PM -
The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective
Mar 10, 2025, 14:00 PM -
Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Analysis of Adherence to Clinical Protocols and Therapeutic Guidelines (PCDT) for Rare Diseases – A Comparison of Real-World Clinical Practice in the Context of the Value-Based Care Journey for RARAS.
Mar 10, 2025, 14:00 PM -
Optimized Treatment Sequences for ALK+ Stage IV NSCLC: Cost-Effectiveness Analysis From RCT data and Real-World Evidence
Mar 10, 2025, 14:00 PM -
How Disease Modifying Therapy Utilization In Multiple Sclerosis Is Influenced by Insurance and Out-Of-Pocket Cost in US Adults: A Summary Of Recent Literature
Mar 10, 2025, 14:00 PM -
Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data
Mar 10, 2025, 14:00 PM -
Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)
Mar 10, 2025, 14:00 PM -
Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM -
Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil
Mar 10, 2025, 14:00 PM -
Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis
Mar 10, 2025, 14:00 PM